Azora Therapeutics, Inc. (DE)
AZR· Nasdaq
Released Nov 13, 2018, after the close
10-Q filed Nov 14, 2018, 45 days after period end · 0001213900-18-015559
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 |
|---|---|---|
| Net Income | -$8.19M | -$292.63K |
| EPS Diluted | -$1.48 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Azora Therapeutics, Inc. (DE) · CIK 1513525 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end